日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Personalized app-based coaching for improving physical activity in heart failure with preserved ejection fraction patients compared with standard care: rationale and design of the MyoMobile Study

针对射血分数保留型心力衰竭患者,个性化应用程序指导能否改善其身体活动水平,并与标准治疗进行比较:MyoMobile 研究的理论基础和设计

Zeid, Silav; Prochaska, Jürgen H; Schuch, Alexander; Tröbs, Sven Oliver; Schulz, Andreas; Münzel, Thomas; Pies, Tanja; Dinh, Wilfried; Michal, Matthias; Simon, Perikles; Wild, Philipp Sebastian

Role of Heart Rate Recovery in Chronic Heart Failure: Results From the MyoVasc Study

心率恢复在慢性心力衰竭中的作用:MyoVasc 研究的结果

Velmeden, David; Söhne, Jakob; Schuch, Alexander; Zeid, Silav; Schulz, Andreas; Troebs, Sven-Oliver; Müller, Felix; Heidorn, Marc W; Buch, Gregor; Belanger, Noémie; Dinh, Wilfried; Mondritzki, Thomas; Lackner, Karl J; Gori, Tommaso; Münzel, Thomas; Wild, Philipp S; Prochaska, Jürgen H

Safety and tolerability of the M2 muscarinic acetylcholine receptor modulator BAY 2413555 in heart failure with reduced ejection fraction in the REMOTE-HF study

REMOTE-HF 研究评估了 M2 毒蕈碱乙酰胆碱受体调节剂 BAY 2413555 在射血分数降低的心力衰竭患者中的安全性和耐受性

Fudim, Marat; Khan, Muhammad Shahzeb; Linz, Dominik; Lindenfeld, JoAnn; MacRae, Calum; Kimmeskamp-Kirschbaum, Nina; Meyer, Michaela; Mondritzki, Thomas; Tinel, Hanna; Dinh, Wilfried; Mentz, Robert J

Cardiac output improvement by pecavaptan: a novel dual-acting vasopressin V1a/V2 receptor antagonist in experimental heart failure

佩卡伐坦改善心输出量:一种新型双效血管加压素V1a/V2受体拮抗剂在实验性心力衰竭中的应用

Mondritzki, Thomas; Mai, Thuy Anh; Vogel, Julia; Pook, Elisabeth; Wasnaire, Pierre; Schmeck, Carsten; Hüser, Jörg; Dinh, Wilfried; Truebel, Hubert; Kolkhof, Peter

Real-Life Multimarker Monitoring in Patients with Heart Failure: Continuous Remote Monitoring of Mobility and Patient-Reported Outcomes as Digital End Points in Future Heart-Failure Trials

真实世界中心力衰竭患者的多标志物监测:将活动能力和患者报告结局的连续远程监测作为未来心力衰竭试验的数字终点

Kramer, Frank; Butler, Javed; Shah, Sanjiv J; Jung, Christian; Nodari, Savina; Rosenkranz, Stephan; Senni, Michele; Bamber, Luke; Cichos, Stephan; Dori, Chrysanthi; Karakoyun, Toeresin; Köhler, Gabriele Jenny; Patel, Kinjal; Piraino, Paolo; Viethen, Thomas; Chennuru, Praneeth; Paydar, Ayse; Sims, Jason; Clark, Richard; van Lummel, Rob; Müller, Alexandra; Gwaltney, Chad; Smajlovic, Salko; Düngen, Hans-Dirk; Dinh, Wilfried

Impact of body mass index on acute outcome in percutaneous coronary intervention of chronic total occlusion

体重指数对经皮冠状动脉介入治疗慢性完全闭塞病变急性期预后的影响

Guelker, Jan-Erik; Bufe, Alexander; Blockhaus, Christian; Gesenberg, Jan; Kuervers, Julian; Kroeger, Knut; Katoh, Marcus; Dinh, Wilfried

Test-Retest Reliability of Non-Invasive Cardiac Output Measurement during Exercise in Healthy Volunteers in Daily Clinical Routine

日常临床实践中健康志愿者运动时无创心输出量测量的重测信度

Barroso, Michael Thomas Coll; Hoppe, Matthias Wilhelm; Boehme, Philip; Krahn, Thomas; Kiefer, Christian; Kramer, Frank; Mondritzki, Thomas; Pirez, Phillipe; Dinh, Wilfried

Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction.

内皮抑素是射血分数保留型心力衰竭的潜在生物标志物

Barroso Michael Coll, Boehme Philip, Kramer Frank, Mondritzki Thomas, Koehler Till, Gülker Jan-Erik, Karoff Martin, Dinh Wilfried

Serum insulin-like growth factor-1 and its binding protein-7: potential novel biomarkers for heart failure with preserved ejection fraction.

血清胰岛素样生长因子-1及其结合蛋白-7:射血分数保留型心力衰竭的潜在新型生物标志物

Barroso Michael Coll, Kramer Frank, Greene Stephen J, Scheyer Daniel, Köhler Till, Karoff Martin, Seyfarth Melchior, Gheorghiade Mihai, Dinh Wilfried

A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels

在非糖尿病患者中,即使血糖水平低于糖尿病标准,冠状动脉造影评估显示其心血管风险也逐渐增加。

Schinner, Sven; Füth, Reiner; Kempf, Kerstin; Martin, Stephan; Willenberg, Holger S; Schott, Matthias; Dinh, Wilfried; Scherbaum, Werner A; Lankisch, Mark